Fabrication additive ou Impression 3D. Aperçus sur une variation terminographique

Materiaalia lisäävä valmistus eli 3D-tulostus on valmistusmenetelmä, jossa kappale tehdään 3D-mallin pohjalta materiaalikerroksia lisäämällä, käyttäen useita tekniikoita ja materiaaleja. Menetelmää sovelletaan useilla teollisuuden aloilla. Lisääviä valmistustekniikoita on kehitetty 1990-luvun alkupuolelta lähtien, ja ne monipuolistuvat jatkuvasti. Tässä pro gradu -tutkielmassa tutkitaan sovellusalan terminologian kehitystä vertailevilla menetelmillä ja luodaan kolmikielinen sanasto alan asiantuntijoille, joita edustaa Suomessa FIRPA ry. Sanaston kielet ovat englanti, ranska ja suomi. Terminologian tutkimus on perinteisesti keskittynyt sanastotyöhön ja käsiteanalyysiin, sen sijaan termihistorian tutkimus on ollut vähäisempää. Tässä työssä on tehty vertailevaa termitutkimusta sekä sanastotyön että termihistorian näkökulmista. Vertailutasoja ovat termien merkityksen muuttuminen, vertailu pivot-kielen suhteen ja kielikohtaisten ominaisuuksien tarkastelu termien muotoutumisessa. Tutkittavia asioita ovat sanastokäsitteiden väliset suhteet, synonyymien, varianttien ja uudissanojen moninaisuus, ja termien yleiskielistyminen. Samalla pohditaan muita termien muuttumiseen vaikuttavia syita. Tärkeimpänä lähteenä käytetään Wohlersin vuosiraportteja, jotka kuvaavat kattavasti koko teollisuudenalaa. Koska englannin pivot-vaikutus on voimakasta teknisillä aloilla, omankielisen terminologian kehittyminen vaatii tietoista terminologiatyötä ja aktiivista omankielisten termien käyttöä. Terminologian vakiintumista voidaan arvioida termivarianttien ja uudissanojen määristä, sekä termien yleiskielistymisestä. Terminologia muuttuu jatkuvasti toimialan kehittyessä ja vaatii säännöllistä päivittämistä. Termihistorian tunteminen tukee sanastotyön termivalintoja. Alan asiantuntijat ovat vastuussa omasta terminologiastaan, ja heidän aktiivisuutensa on tärkeää sen kehittämisessä. Toteutettu sanasto on tämän pro gradu -tutkielman liitteenä ja se julkaistaan myös FIRPA ry:n Internet-sivustolla. Suomenkielinen osio sanastosta on ensimmäinen laaja suomeksi julkaistu materiaalia lisäävän valmistuksen sanasto.Siirretty Doriast

Debt Judgments as a Reflection of Consumption-Related Debt Problems

Peer reviewe

Undergraduate curriculum in palliative medicine at Tampere University increases students' knowledge

Background: Education in palliative medicine (PM) at medical schools reveals wide variation despite the increasing importance of palliative care. Many universities present poor description of the benefits and detailed content of the total curriculum in PM. Using the recommendations of European Association for Palliative Care (EAPC) as a reference, we evaluated the content and outcomes of the curriculum in PM at the University of Tampere, Finland. Methods: We searched for a PM curriculum by examining the teaching offered by every specialty and compared it to EAPC recommendations. Students' knowledge was evaluated using a progress test over three consecutive years. Results: We found 53.5 teaching hours addressing PM issues, which exceeds the recommendation of the EAPC. Basics, symptom management, ethics, and communication skills were well established, while education in psychosocial/spiritual aspects, teamwork and self-reflection failed to reach the recommendations. Out of the maximum of 4.0, the progress test mean scores in PM among the third, fourth, fifth and sixth year students were 0.1 (SD 0.71), 0.69 (SD 1.28), 1.38 (SD 1.46) and 2.53 (SD 1.26), respectively (p <0.001). This growing knowledge was associated with the timely increase in teaching provided through the PM discipline. In addition, the students who completed the optional PM course achieved better mean scores (2.66; SD 1.27) than the others (1.33; SD 1.43) (p <0.001). Conclusions: The curriculum in PM at the University of Tampere is integrated into the teaching of many disciplines and complied well with the EAPC recommendations. This education led to increasing knowledge in PM among medical students.Peer reviewe

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland

Chlamydia trachomatis, Mycoplasma genitalium, herpes simplex virus (HSV) and human papillomavirus (HPV) cause sexually transmitted infections. In addition, human herpesvirus 6 (HHV-6) may be a genital co-pathogen. The prevalence rates of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes were investigated by PCR in urogenital samples of the C. trachomatis nucleic acid amplification test positive (n = 157) and age-, community- and time-matched negative (n = 157) women. The prevalence of HPV DNA was significantly higher among the C. trachomatis positives than the C. trachomatis negatives (66% vs. 25%, p < 0.001). The prevalence of HSV (1.9% vs. 0%), HHV-6 (11% vs. 14%), and M. genitalium DNA (4.5% vs. 1.9%) was not significantly different between the C. trachomatis-positive and -negative women. Thirteen per cent of test-of-cure specimens tested positive for C. trachomatis. The prevalence of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes did not significantly differ between those who cleared the C. trachomatis infection (n = 105) and those who did not (n = 16). The higher prevalence of HPV DNA among the C. trachomatis positives suggests greater sexual activity and increased risk for sexually transmitted pathogens

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland

Chlamydia trachomatis, Mycoplasma genitalium, herpes simplex virus (HSV) and human papillomavirus (HPV) cause sexually transmitted infections. In addition, human herpesvirus 6 (HHV-6) may be a genital co-pathogen. The prevalence rates of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes were investigated by PCR in urogenital samples of the C. trachomatis nucleic acid amplification test positive (n = 157) and age-, community- and time-matched negative (n = 157) women. The prevalence of HPV DNA was significantly higher among the C. trachomatis positives than the C. trachomatis negatives (66% vs. 25%, p <0.001). The prevalence of HSV (1.9% vs. 0%), HHV-6 (11% vs. 14%), and M. genitalium DNA (4.5% vs. 1.9%) was not significantly different between the C. trachomatis-positive and -negative women. Thirteen per cent of test-of-cure specimens tested positive for C. trachomatis. The prevalence of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes did not significantly differ between those who cleared the C. trachomatis infection (n = 105) and those who did not (n = 16). The higher prevalence of HPV DNA among the C. trachomatis positives suggests greater sexual activity and increased risk for sexually transmitted pathogens.Peer reviewe

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland

Chlamydia trachomatis, Mycoplasma genitalium, herpes simplex virus (HSV) and human papillomavirus (HPV) cause sexually transmitted infections. In addition, human herpesvirus 6 (HHV-6) may be a genital co-pathogen. The prevalence rates of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes were investigated by PCR in urogenital samples of the C. trachomatis nucleic acid amplification test positive (n = 157) and age-, community- and time-matched negative (n = 157) women. The prevalence of HPV DNA was significantly higher among the C. trachomatis positives than the C. trachomatis negatives (66% vs. 25%, p < 0.001). The prevalence of HSV (1.9% vs. 0%), HHV-6 (11% vs. 14%), and M. genitalium DNA (4.5% vs. 1.9%) was not significantly different between the C. trachomatis-positive and -negative women. Thirteen per cent of test-of-cure specimens tested positive for C. trachomatis. The prevalence of HSV, HHV-6, HPV, M. genitalium, and the C. trachomatis ompA genotypes did not significantly differ between those who cleared the C. trachomatis infection (n = 105) and those who did not (n = 16). The higher prevalence of HPV DNA among the C. trachomatis positives suggests greater sexual activity and increased risk for sexually transmitted pathogens

Side-stream products of malting: a neglected source of phytochemicals

Whole grain consumption reduces the risk of several chronic diseases. A major contributor to the effect is the synergistic and additive effect of phytochemicals. Malting is an important technological method to process whole grains; the main product, malted grain, is used mainly for brewing, but the process also yields high amounts of side-stream products, such as rootlet. In this study, we comprehensively determined the phytochemical profile of barley, oats, rye, and wheat in different stages of malting and the subsequent extraction phases to assess the potential of malted products and side-streams as a dietary source of bioactive compounds. Utilizing semi-quantitative LC–MS metabolomics, we annotated 285 phytochemicals from the samples, belonging to more than 13 chemical classes. Malting significantly altered the levels of the compounds, many of which were highly increased in the rootlet. Whole grain cereals and the malting products were found to be a diverse and rich source of phytochemicals, highlighting the value of these whole foods as a staple. The characterization of phytochemicals from the 24 different sample types revealed previously unknown existence of some of the compound classes in certain species. The rootlet deserves more attention in human nutrition, rather than its current use mainly as feed, to benefit from its high content of bioactive components

Tulevaisuus - paljon mahdollista – Tulevaisuusohjauksen ajatuksia ja tekoja

T&auml;m&auml; k&auml;sikirja on tarkoitettu opiskelijoiden&nbsp;ja muiden oppijoiden uraohjausty&ouml;t&auml;&nbsp;tekeville ja siit&auml; kiinnostuneille. Kuvailemme&nbsp;sek&auml; tulevaisuusohjauksen l&auml;ht&ouml;kohtia&nbsp;ett&auml; sen tueksi kehitettyj&auml; ty&ouml;kaluja.&nbsp;Tulevaisuusohjaus on kehitteill&auml;&nbsp;oleva viitekehys, jonka keskeinen ajatus&nbsp;on yhdist&auml;&auml; pitk&auml;n aikav&auml;lin tulevaisuusajattelua&nbsp;kokonaisvaltaiseen opinto- ja&nbsp;uraohjaukseen. Kirjassa esitell&auml;&auml;n&nbsp;ty&ouml;kaluja, jotka on kehitetty erityisesti&nbsp;tukemaan nuorten alle 30-vuotiaiden&nbsp;koulutusvalintojen tekemist&auml; ja ty&ouml;el&auml;m&auml;&auml;n siirtymist&auml;.&nbsp; K&auml;sikirjan tarkoituksena on kertoa,&nbsp;mit&auml; uutta tulevaisuusohjaus tuo ja&nbsp;toisaalta, miten se liittyy nykyisiin&nbsp;opinto- ja uraohjauksen suuntauksiin.&nbsp;Pyrimme antamaan ajatuksia ja vinkkej&auml;&nbsp;siit&auml;, miten voit ohjata ajattelemaan&nbsp;tulevaisuuden ty&ouml;el&auml;m&auml;&auml; tai auttaa koulutusvalinnoissa.&nbsp;Tulevaisuusty&ouml;kalujen&nbsp;esittelyn lis&auml;ksi mukana on esimerkkej&auml;&nbsp;ty&ouml;kalujen k&auml;yt&ouml;st&auml; opetuksessa ja ohjauksessa.&nbsp;K&auml;sikirja sis&auml;lt&auml;&auml; harjoituksia,&nbsp;tuntimalleja ja kurssisuunnitelmia.</p

Genomic epidemiology of nosocomial carbapenemase-producing Citrobacter freundii in sewerage systems in the Helsinki metropolitan area, Finland

Multi-drug resistance is emerging in Citrobacter freundii, which is the third most common carbapenemase-producing (CP) Enterobacteriaceae in humans in Finland due to recent outbreaks. The objective of this study was to determine if wastewater surveillance (WWS) could detect CP C. freundii strains causing infections in humans. Selective culturing was used to isolate CP C. freundii from the hospital environment, hospital wastewater, and untreated municipal wastewater in Helsinki, Finland, between 2019 and 2022. Species were identified using MALDI-TOF, and presumptive CP C. freundii isolates were subjected to antimicrobial susceptibility testing and further characterized by whole genome sequencing. A genomic comparison was conducted to compare isolates collected from the hospital environment, untreated municipal wastewater, and a selection of isolates from human specimens from two hospitals in the same city. We also examined the persistence of CP C. freundii in the hospital environment and the impact of our attempts to eradicate it. Overall, 27 blaKPC − 2-carrying C. freundii were detected in the hospital environment (ST18; n = 23 and ST8; n = 4), while 13 blaKPC − 2-carrying C. freundii (ST8) and five blaVIM − 1-carrying (ST421) C. freundii were identified in untreated municipal wastewater. CP C. freundii was not identified in hospital wastewater. We found three clusters (cluster distance threshold ≤ 10 allelic difference) after comparing the recovered isolates and a selection of isolates from human specimens. The first cluster consisted of ST18 isolates from the hospital environment (n = 23) and human specimens (n = 4), the second consisted of ST8 isolates from the hospital environment (n = 4), untreated municipal wastewater (n = 6), and human specimens (n = 2), and the third consisted of ST421 isolates from the untreated municipal wastewater (n = 5). Our results support previous studies suggesting that the hospital environment could act as a source of transmission of CP C. freundii in clinical settings. Furthermore, the eradication of CP Enterobacteriaceae from the hospital environment is challenging. Our findings also showed that CP C. freundii is persistent throughout the sewerage system and demonstrate the potential of WWS for detecting CP C. freundii.Peer reviewe

Pharmacokinetic aspects of retinal drug delivery

Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.Peer reviewe